Brasília – The federal government will finance oncology medicines through three distinct mechanisms, according to a new ordinance from the Ministry of Health. The measure establishes a clearer framework for the procurement and distribution of cancer drugs within the Unified Health System (SUS), aiming to improve access, coordination, and financial predictability.

The three modalities include: direct acquisition by the Ministry of Health, shared procurement between federal, state, and municipal levels, and targeted funding through partnerships with authorized institutions. The model seeks to streamline the supply of high-cost oncology treatments, reduce regional disparities, and ensure continuity of care for cancer patients.

According to the Ministry, the reform also aligns with the National Policy for Pharmaceutical Assistance, creating more transparent governance for cancer drug financing and reducing reliance on judicial decisions for patient access.

Source: JOTA

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com